Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
Reuters· 11 小時前Novartis breast cancer drug Kisqali cut the risk of recurrence by a little more than 25% in a ...
Q&A: Fay Grant On Bringing Her Entrepreneur Spirit To Fighting RFC1-CANVAS
Forbes· 18 小時前At 35 years old, Fay Grant was a mother of a beautiful daughter, happily married and had ...
Council Post: Three Ways Life Science Companies Can Focus On Quality Improvement
Forbes· 2 日前Robert Fenton is the founder and CEO of Qualio, a cloud-based quality management system (eQMS) ...